These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20044177)

  • 1. [Ataxia secondary to valproate. The importance of the choice of anti-epileptic treatment in the elderly].
    Gutiérrez Rodríguez J
    Rev Esp Geriatr Gerontol; 2010; 45(1):52-3. PubMed ID: 20044177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Caution rules when prescribing valproate].
    Jensen K
    Ugeskr Laeger; 1995 Oct; 157(42):5875-6. PubMed ID: 7483072
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute chorea caused by valproate in an elderly.
    van de Velde K; Cras P; Helsen G
    Acta Neurol Belg; 2011 Sep; 111(3):220-1. PubMed ID: 22141287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cognitive and neurological symptoms during valproic acid therapy.
    Hommet C; Mondon K; de Toffol B; Constans T
    J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stupor associated with the treatment of epilepsy with valproate].
    Skjødt T; Sørensen T
    Ugeskr Laeger; 1984 Apr; 146(15):1137-8. PubMed ID: 6429914
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced hyperammonemia.
    Batshaw ML; Brusilow SW
    Ann Neurol; 1982 Mar; 11(3):319-21. PubMed ID: 6807193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prior to new drug approval: improve the routines of license prescriptions].
    Lundberg B; Nergårdh A; Boréus LO
    Lakartidningen; 1996 Feb; 93(7):597-600. PubMed ID: 8642925
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
    Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
    An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G; Marková J; Mastík J
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.
    Ratnaike RN; Schapel GJ; Purdie G; Rischbieth RH; Hoffmann S
    Br J Clin Pharmacol; 1986 Jul; 22(1):100-3. PubMed ID: 3091053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stuporous states during treatment with sodium valproate. Pathogenetic hypotheses].
    Marescaux C; Rumbach L; Warter JM; Collard M; Rohmer F; Micheletti G; Kurtz D; Koehl C
    Rev Neurol (Paris); 1981; 137(4):241-54. PubMed ID: 6792680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-associated dysmyelopoiesis in elderly patients.
    So CC; Wong KF
    Am J Clin Pathol; 2002 Aug; 118(2):225-8. PubMed ID: 12162682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
    Hayashi T; Yoshida S; Yoshinaga A; Ohno R; Ishii N; Yamada T
    Scand J Urol Nephrol; 2005; 39(5):431-2. PubMed ID: 16257847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.